Onco Innovations (ONCO.C): What if we could stop cancer coming back?
Vancouver Resource Investment Conference 2025 comes to a close: Here’s what we saw
Purebread Brands (BRED.V): The best thing since sliced bread got crap
Voyageur Pharmaceuticals (VM) took a mine and turned it into a pharma company
Can your phone confirm you have strep throat? Light AI (ALGO.E) says yes
Prospera Energy (PEI.V)’s big corporate evolution: From incompetence to dishonesty
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.
Today, we focus on Diagnos (ADK.V) which leverages proprietary AI technology and retinal scanning to revolutionize diagnosis methodology for such conditions as diabetes.
Enjoy!
